Top Stock Movers Today — September 11, 2026: Why BDRX, ACVA and FTFT Surged

BDRX — Biodexa Pharmaceuticals Plc (+96.9%)

Biodexa Pharmaceuticals closed Friday at $1.30, nearly doubling in a single session on volume of 40,678,090 shares — roughly 13× its 20-day average of 3,052,504. That kind of volume explosion on a sub-$2 stock signals a crowd has piled in fast, which demands extra caution: the same rush that ignites a move like this can reverse just as quickly.

Why it moved: Biodexa published its interim results for the six months ended June 30, 2026 on September 11 (via Yahoo Finance). The filing also surfaced in Friday's pre-market healthcare movers lists on Benzinga and in a broader roundup of European ADRs trading higher on US exchanges. Biodexa is a UK-based biotech traded in the US as an American Depositary Receipt (an ADR allows foreign shares to trade on US markets in US dollars). The specific contents of the interim results — positive data, revenue beats, or pipeline news — are what appears to have lit the fuse, though we can only confirm the catalyst type from the data in hand, not its precise details.

Technical picture: StockSetups assigned a conviction score of 24/100 and a D grade, with the moving-average stack still bearish — a reminder that the underlying trend was not strong before today's explosion. The RSI (Relative Strength Index, a momentum gauge where readings above 70 suggest overbought territory) sits at 55, meaning momentum was not extreme at the close despite the size of the move. The stock gapped up +33.7% at the open and kept climbing. It remains 88.1% below its 52-week high, underscoring how far it has already fallen over the past year — this session recovered only a fraction of lost ground. The ADX (a trend-strength indicator) at 45 confirms strong directional momentum today, but direction and sustainability are two different things.

Short / squeeze read: The short-squeeze score is 49/100. A short squeeze happens when traders who have bet against a stock (short sellers) are forced to buy shares to close their positions, amplifying an upward move. With only 4,812 shares of reported short interest and essentially 0.0 days to cover, this doesn't look like a classic squeeze scenario — the move is more likely news-driven than squeeze-driven. Short volume was 62% of today's total, suggesting active two-way trading rather than a one-sided stampede.

ACVA — ACV Auctions Inc. (+44.2%)

ACV Auctions closed Friday at $10.41, up 44.2% on the day, on volume of 28,581,423 shares — more than 5× its 20-day average of 5,296,890. This is a $1.8 billion market-cap company in the Consumer Discretionary sector, so the move carries more institutional weight than your typical micro-cap runner. ACVA also appeared in this morning's premarket movers recap, where it was already surging before the open — the full-day gain landed at 44.2%.

Why it moved: The catalyst is clear and significant. Copart struck a $1.9 billion deal to acquire ACV Auctions, per Yahoo Finance's headline: "ACV Auctions Soars 40% as Copart Strikes $1.9B Deal." SEC filings confirm the corporate activity: ACV filed an 8-K (material agreement) on September 10 and a SC TO-C (tender offer communication) the same day. A tender offer is when an acquirer offers to buy shareholders' shares directly, typically at a premium — which explains the gap to today's price. Needham downgraded ACVA on the acquisition news (Investing.com), which is typical when analysts believe the deal price leaves little further upside. Morningstar also flagged a shareholder class-action investigation into whether the deal is fair to shareholders, another common development in M&A situations.

Technical picture: StockSetups gave ACVA a conviction score of 92/100 and an A+ grade — its highest-tier rating — with a bullish MA stack and a Trend Template score of 6/6, meaning it was already in a strong uptrend before the deal news landed. The stock gapped up +44.8% at the open and held those gains, closing at a 52-week high. The RSI of 79 is firmly in overbought territory, and the RS (Relative Strength) rating of 89 means it has been outperforming most of the market. The technical rank of 96 places it near the very top of the StockSetups universe. With a tender offer on the table, the "trade" here is largely about deal arbitrage (betting on whether the deal closes at the offered price) rather than a traditional technical setup — a different risk profile entirely.

Short / squeeze read: The squeeze score is 45/100, with 15,210,588 shares short and 2.3 days to cover (the number of days it would take short sellers to buy back all their shares at average daily volume). Short-volume was just 32% today, suggesting the buying was not primarily short-covering but genuine new demand driven by the deal announcement. The free float — the shares available for public trading — is 95.4%, so there's no float-squeeze dynamic at play here.

FTFT — Future FinTech Group Inc. (+40.0%)

Future FinTech Group closed Friday at $2.87, up 40.0% on volume of 23,492,006 shares — roughly 2.6× its 20-day average of 9,203,999. This is a micro-cap with a market cap of just $92.5 million in the Consumer Discretionary sector. FTFT also featured in Wednesday September 9's after-close recap, where it gained 59.5% with no new filing. Back-to-back big moves in a few days on a micro-cap are a yellow flag: this name is in active speculative play.

Why it moved: No clear fresh catalyst accompanied today's move. There were no new SEC filings on September 11; the most recent were a routine 8-K (bylaws update) on August 26 and a 10-Q (quarterly report) on August 14, neither of which is a typical price mover. Headlines in the data are from September 9–10, not today, and include references to FTFT as a prior-session winner and a mention of heavy volume (79 million shares in a prior session) with no new filing — a pattern that has now repeated. The catalyst is unclear; this move appears momentum- and technically-driven, likely carrying forward the speculative energy from earlier in the week.

Technical picture: The StockSetups candle for today is a gravestone doji — a candlestick pattern where the stock opens near its low, rallies significantly intraday, but then gives back most of those gains to close near where it opened. It's often read as a warning sign that buying pressure is exhausted. Despite closing up 40%, the gravestone doji suggests the intraday high was much higher than $2.87. The RSI of 75 is in overbought territory, the ADX of 33 confirms a trending move, and the MA stack is mixed — not a clean bullish alignment. The RS rating of 96 and technical rank of 98 are top-decile figures, and StockSetups assigned a conviction score of 77/100 with an A grade and a Trend Template score of 5/6. The stock is still 9.8% below its 52-week high, meaning it has not yet reclaimed prior peaks.

Short / squeeze read: The squeeze score is a modest 32/100, with only 55,361 shares short and 0.7 days to cover — essentially no short interest to squeeze. Short-volume was 55% of today's total, which is relatively elevated and may reflect active intraday traders fading the move. The free float is a notably tight 56.9% — meaning fewer than 57% of total shares are freely tradeable — which can amplify price swings in either direction when volume surges. With so little short interest, any continued move here would need genuine new buyers, not short-covering, to sustain it.

The bottom line

Friday, September 11, 2026 served up three very different types of movers. BDRX was a news-driven biotech explosion on interim results, in a stock that remains deep below its 52-week highs with a bearish underlying trend. ACVA moved on concrete M&A news — a $1.9 billion Copart tender offer — making it a deal-arb situation more than a technical trade, with a class-action investigation already underway. FTFT is a repeat momentum runner with no fresh catalyst, a gravestone doji warning candle, and a tight float that amplifies volatility in both directions.

All three of these stocks are high-risk names. Chasing extended gainers after a 40–97% single-day move is one of the most dangerous habits in trading. Big one-day movers frequently give back a large portion of their gains in the sessions that follow, especially when there is no durable fundamental catalyst, or when a deal arbitrage situation introduces new uncertainties. Chart patterns, squeeze setups, and momentum signals all fail regularly — none of them guarantee continuation.

Manage your risk, size positions conservatively, and always do your own research before acting. StockSetups scans the full ~12,300-stock US universe after every close, detecting confirmed chart patterns and ranking setups by conviction, short-squeeze potential, and smart-money signals — so you can see the full picture before markets open again Monday morning.